Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Infliximab
Remicade
Not routinely available
SMC (739/11)
10/10/2011
Indication
Treatment of moderately active Crohn' s disease.
Therapeutic Area
Gastro-intestinal system
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
100mg powder for concentrate for solution for infusion
Comments
None
Link to Advice
Advice Published
10/10/2011
SMC Submission Type
Non submission
SMC Status
Not recommended